{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T17:33:01Z","timestamp":1791999181399,"version":"4.4.0"},"reference-count":158,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T00:00:00Z","timestamp":1763510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T00:00:00Z","timestamp":1763510400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Rev Rheumatol"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1038\/s41584-025-01321-x","type":"journal-article","created":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T11:14:09Z","timestamp":1763550849000},"page":"26-41","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Insights into the pathogenesis of childhood-onset SLE in the past decade"],"prefix":"10.1038","volume":"22","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7473-7652","authenticated-orcid":false,"given":"George A.","family":"Robinson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4278-9049","authenticated-orcid":false,"given":"Andrea","family":"Knight","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lori B.","family":"Tucker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4902-5332","authenticated-orcid":false,"given":"Alexandre","family":"Belot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9514-2455","authenticated-orcid":false,"given":"David A.","family":"Isenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8911-4113","authenticated-orcid":false,"given":"Coziana","family":"Ciurtin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,19]]},"reference":[{"key":"1321_CR1","doi-asserted-by":"publisher","first-page":"2669","DOI":"10.1002\/art.34472","volume":"64","author":"LT Hiraki","year":"2012","unstructured":"Hiraki, L. T. et al. Prevalence, incidence, and demographics of systemic lupus erythematosus and lupus nephritis from 2000 to 2004 among children in the US Medicaid beneficiary population. Arthritis Rheum. 64, 2669\u20132676 (2012).","journal-title":"Arthritis Rheum."},{"key":"1321_CR2","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1038\/s41584-021-00668-1","volume":"17","author":"MRW Barber","year":"2021","unstructured":"Barber, M. R. W. et al. Global epidemiology of systemic lupus erythematosus. Nat. Rev. Rheumatol. 17, 515\u2013532 (2021).","journal-title":"Nat. Rev. Rheumatol."},{"key":"1321_CR3","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1002\/acr.24827","volume":"74","author":"MO Valenzuela-Almada","year":"2022","unstructured":"Valenzuela-Almada, M. O. et al. Epidemiology of childhood-onset systemic lupus erythematosus: a population-based study. Arthritis Care Res. 74, 728\u2013732 (2022).","journal-title":"Arthritis Care Res."},{"key":"1321_CR4","doi-asserted-by":"publisher","first-page":"1542","DOI":"10.1177\/0961203316644333","volume":"25","author":"N Ambrose","year":"2016","unstructured":"Ambrose, N. et al. Differences in disease phenotype and severity in SLE across age groups. Lupus 25, 1542\u20131550 (2016).","journal-title":"Lupus"},{"key":"1321_CR5","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1177\/0961203307087875","volume":"17","author":"LB Tucker","year":"2008","unstructured":"Tucker, L. B. et al. Adolescent onset of lupus results in more aggressive disease and worse outcomes: results of a nested matched case-control study within LUMINA, a multiethnic US cohort (LUMINA LVII). Lupus 17, 314\u2013322 (2008).","journal-title":"Lupus"},{"key":"1321_CR6","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1002\/art.24091","volume":"61","author":"AO Hersh","year":"2009","unstructured":"Hersh, A. O. et al. Differences in long-term disease activity and treatment of adult patients with childhood- and adult-onset systemic lupus erythematosus. Arthritis Rheum. 61, 13\u201320 (2009).","journal-title":"Arthritis Rheum."},{"key":"1321_CR7","doi-asserted-by":"publisher","first-page":"1788","DOI":"10.1136\/annrheumdis-2016-210960","volume":"76","author":"N Groot","year":"2017","unstructured":"Groot, N. et al. European evidence-based recommendations for diagnosis and treatment of childhood-onset systemic lupus erythematosus: the SHARE initiative. Ann. Rheum. Dis. 76, 1788\u20131796 (2017).","journal-title":"Ann. Rheum. Dis."},{"key":"1321_CR8","doi-asserted-by":"publisher","first-page":"1110","DOI":"10.1177\/09612033251366394","volume":"34","author":"SHS Lan\u00e7as","year":"2025","unstructured":"Lan\u00e7as, S. H. S. et al. A Brazilian single-centre series comparision of childhood, adult and late onset systemic lupus erythematosus. Lupus 34, 1110\u20131118 (2025).","journal-title":"Lupus"},{"key":"1321_CR9","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1093\/oxfordjournals.aje.a009122","volume":"145","author":"S Manzi","year":"1997","unstructured":"Manzi, S. et al. Age-specific incidence rates of myocardial infarction and angina in women with systemic lupus erythematosus: comparison with the Framingham Study. Am. J. Epidemiol. 145, 408\u2013415 (1997).","journal-title":"Am. J. Epidemiol."},{"key":"1321_CR10","doi-asserted-by":"publisher","first-page":"1152","DOI":"10.1002\/acr.20179","volume":"62","author":"AO Hersh","year":"2010","unstructured":"Hersh, A. O. et al. Childhood-onset disease as a predictor of mortality in an adult cohort of patients with systemic lupus erythematosus. Arthritis Care Res. 62, 1152\u20131159 (2010).","journal-title":"Arthritis Care Res."},{"key":"1321_CR11","doi-asserted-by":"publisher","DOI":"10.1136\/lupus-2022-000817","volume":"10","author":"HI Brunner","year":"2023","unstructured":"Brunner, H. I. et al. Treatment patterns in paediatric and adult patients with SLE: a retrospective claims database study in the USA. Lupus Sci. Med. 10, e000817 (2023).","journal-title":"Lupus Sci. Med."},{"key":"1321_CR12","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1002\/acr.24430","volume":"73","author":"N Aljaberi","year":"2021","unstructured":"Aljaberi, N. et al. Performance of the new 2019 European League Against Rheumatism\/American College of Rheumatology Classification criteria for systemic lupus erythematosus in children and young adults. Arthritis Care Res. 73, 580\u2013585 (2021).","journal-title":"Arthritis Care Res."},{"key":"1321_CR13","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1191\/0961203306lu2291oa","volume":"15","author":"HI Brunner","year":"2006","unstructured":"Brunner, H. I. et al. Disease outcomes and ovarian function of childhood-onset systemic lupus erythematosus. Lupus 15, 198\u2013206 (2006).","journal-title":"Lupus"},{"key":"1321_CR14","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1002\/art.40697","volume":"71","author":"N Groot","year":"2019","unstructured":"Groot, N. et al. Long-term clinical outcomes in a cohort of adults with childhood-onset systemic lupus erythematosus. Arthritis Rheumatol. 71, 290\u2013301 (2019).","journal-title":"Arthritis Rheumatol."},{"key":"1321_CR15","doi-asserted-by":"publisher","first-page":"3378","DOI":"10.1093\/rheumatology\/keab915","volume":"61","author":"EMD Smith","year":"2022","unstructured":"Smith, E. M. D. et al. Attainment of low disease activity and remission targets reduces the risk of severe flare and new damage in childhood Lupus. Rheumatology 61, 3378\u20133389 (2022).","journal-title":"Rheumatology"},{"key":"1321_CR16","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1136\/annrheumdis-2017-211613","volume":"77","author":"M Zen","year":"2018","unstructured":"Zen, M. et al. Lupus low disease activity state is associated with a decrease in damage progression in Caucasian patients with SLE, but overlaps with remission. Ann. Rheum. Dis. 77, 104\u2013110 (2018).","journal-title":"Ann. Rheum. Dis."},{"key":"1321_CR17","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1002\/acr.22774","volume":"68","author":"CV Medina-Qui\u00f1ones","year":"2016","unstructured":"Medina-Qui\u00f1ones, C. V. et al. Analysis of complete remission in systemic lupus erythematosus patients over a 32-year period. Arthritis Care Res. 68, 981\u2013987 (2016).","journal-title":"Arthritis Care Res."},{"key":"1321_CR18","doi-asserted-by":"publisher","DOI":"10.1186\/s13075-016-1163-2","volume":"18","author":"V Golder","year":"2016","unstructured":"Golder, V. et al. Frequency and predictors of the lupus low disease activity state in a multi-national and multi-ethnic cohort. Arthritis Res. Ther. 18, 260 (2016).","journal-title":"Arthritis Res. Ther."},{"key":"1321_CR19","doi-asserted-by":"publisher","first-page":"e451","DOI":"10.1016\/S2665-9913(20)30217-4","volume":"2","author":"MY Choi","year":"2020","unstructured":"Choi, M. Y. & Ma, C. Making a big impact with small datasets using machine-learning approaches. Lancet Rheumatol. 2, e451\u2013e452 (2020).","journal-title":"Lancet Rheumatol."},{"key":"1321_CR20","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1007\/s40272-021-00457-z","volume":"23","author":"VC Trindade","year":"2021","unstructured":"Trindade, V. C. et al. An update on the management of childhood-onset systemic lupus erythematosus. Paediatr. Drugs 23, 331\u2013347 (2021).","journal-title":"Paediatr. Drugs"},{"key":"1321_CR21","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1038\/s41584-024-01152-2","volume":"20","author":"Y Ghodke-Puranik","year":"2024","unstructured":"Ghodke-Puranik, Y., Olferiev, M. & Crow, M. K. Systemic lupus erythematosus genetics: insights into pathogenesis and implications for therapy. Nat. Rev. Rheumatol. 20, 635\u2013648 (2024).","journal-title":"Nat. Rev. Rheumatol."},{"key":"1321_CR22","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgen.1001311","volume":"7","author":"KE Taylor","year":"2011","unstructured":"Taylor, K. E. et al. Risk alleles for systemic lupus erythematosus in a large case-control collection and associations with clinical subphenotypes. PLoS Genet. 7, e1001311 (2011).","journal-title":"PLoS Genet."},{"key":"1321_CR23","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-50710-5","volume":"15","author":"Q Wang","year":"2024","unstructured":"Wang, Q. et al. High-throughput identification of functional regulatory SNPs in systemic lupus erythematosus. Nat. Commun. 15, 6804 (2024).","journal-title":"Nat. Commun."},{"key":"1321_CR24","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1097\/BOR.0000000000001072","volume":"37","author":"A Charras","year":"2025","unstructured":"Charras, A. et al. Genetic and epigenetic factors shape phenotypes and outcomes in systemic lupus erythematosus \u2014 focus on juvenile-onset systemic lupus erythematosus. Curr. Opin. Rheumatol. 37, 149\u2013163 (2025).","journal-title":"Curr. Opin. Rheumatol."},{"key":"1321_CR25","doi-asserted-by":"publisher","DOI":"10.1136\/rmdopen-2023-003293","volume":"10","author":"YJ Chen","year":"2024","unstructured":"Chen, Y. J. et al. Polygenic risk score predicts earlier-onset adult systemic lupus erythematosus and first-year renal diseases in a Taiwanese cohort. RMD Open 10, e003293 (2024).","journal-title":"RMD Open"},{"key":"1321_CR26","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1136\/ard.2010.141697","volume":"70","author":"R Webb","year":"2011","unstructured":"Webb, R. et al. Early disease onset is predicted by a higher genetic risk for lupus and is associated with a more severe phenotype in lupus patients. Ann. Rheum. Dis. 70, 151\u2013156 (2011).","journal-title":"Ann. Rheum. Dis."},{"key":"1321_CR27","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1093\/rheumatology\/kez220","volume":"59","author":"D Webber","year":"2020","unstructured":"Webber, D. et al. Association of systemic lupus erythematosus (SLE) genetic susceptibility loci with lupus nephritis in childhood-onset and adult-onset SLE. Rheumatology 59, 90\u201398 (2020).","journal-title":"Rheumatology"},{"key":"1321_CR28","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1002\/acr.23931","volume":"72","author":"NA Sinicato","year":"2020","unstructured":"Sinicato, N. A. et al. Familial aggregation of childhood- and adulthood-onset systemic lupus erythematosus. Arthritis Care Res. 72, 1147\u20131151 (2020).","journal-title":"Arthritis Care Res."},{"key":"1321_CR29","doi-asserted-by":"publisher","DOI":"10.1016\/j.clim.2024.110194","volume":"262","author":"Y Renaudineau","year":"2024","unstructured":"Renaudineau, Y. et al. Type I interferon associated epistasis may contribute to early disease-onset and high disease activity in juvenile-onset lupus. Clin. Immunol. 262, 110194 (2024).","journal-title":"Clin. Immunol."},{"key":"1321_CR30","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2025.103451","volume":"155","author":"Y Renaudineau","year":"2025","unstructured":"Renaudineau, Y. et al. Common Toll-like receptor 7 variants define disease risk and phenotypes in juvenile-onset systemic lupus erythematosus. J. Autoimmun. 155, 103451 (2025).","journal-title":"J. Autoimmun."},{"key":"1321_CR31","doi-asserted-by":"publisher","DOI":"10.1016\/j.clim.2025.110540","volume":"279","author":"V Natoli","year":"2025","unstructured":"Natoli, V. et al. Genetic variability associates with ancestry, age at disease onset, organ involvement and disease severity in juvenile-onset systemic lupus erythematosus. Clin. Immunol. 279, 110540 (2025).","journal-title":"Clin. Immunol."},{"key":"1321_CR32","doi-asserted-by":"publisher","first-page":"1524","DOI":"10.1002\/art.43227","volume":"77","author":"R Carlomagno","year":"2025","unstructured":"Carlomagno, R. et al. Genetics of childhood-onset systemic lupus erythematosus. Arthritis Rheumatol. 77, 1524\u20131532 (2025).","journal-title":"Arthritis Rheumatol."},{"key":"1321_CR33","doi-asserted-by":"publisher","first-page":"e99","DOI":"10.1016\/S2665-9913(19)30142-0","volume":"2","author":"A Belot","year":"2020","unstructured":"Belot, A. et al. Contribution of rare and predicted pathogenic gene variants to childhood-onset lupus: a large, genetic panel analysis of British and French cohorts. Lancet Rheumatol. 2, e99\u2013e109 (2020).","journal-title":"Lancet Rheumatol."},{"key":"1321_CR34","doi-asserted-by":"publisher","DOI":"10.1186\/1546-0096-10-21","volume":"10","author":"A Belot","year":"2012","unstructured":"Belot, A. & Cimaz, R. Monogenic forms of systemic lupus erythematosus: new insights into SLE pathogenesis. Pediatr. Rheumatol. Online J. 10, 21 (2012).","journal-title":"Pediatr. Rheumatol. Online J."},{"key":"1321_CR35","doi-asserted-by":"publisher","first-page":"SI210","DOI":"10.1093\/rheumatology\/keac275","volume":"62","author":"A Charras","year":"2023","unstructured":"Charras, A. et al. Panel sequencing links rare, likely damaging gene variants with distinct clinical phenotypes and outcomes in juvenile-onset SLE. Rheumatology 62, SI210\u2013SI225 (2023).","journal-title":"Rheumatology"},{"key":"1321_CR36","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2016.00036","volume":"7","author":"KE Lintner","year":"2016","unstructured":"Lintner, K. E. et al. Early components of the complement classical activation pathway in human systemic autoimmune diseases. Front. Immunol. 7, 36 (2016).","journal-title":"Front. Immunol."},{"key":"1321_CR37","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1038\/s41586-022-04642-z","volume":"605","author":"GJ Brown","year":"2022","unstructured":"Brown, G. J. et al. TLR7 gain-of-function genetic variation causes human lupus. Nature 605, 349\u2013356 (2022).","journal-title":"Nature"},{"key":"1321_CR38","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20232066","volume":"221","author":"C David","year":"2024","unstructured":"David, C. et al. Gain-of-function human UNC93B1 variants cause systemic lupus erythematosus and chilblain lupus. J. Exp. Med. 221, e20232066 (2024).","journal-title":"J. Exp. Med."},{"key":"1321_CR39","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1038\/s41590-024-01846-5","volume":"25","author":"M Al-Azab","year":"2024","unstructured":"Al-Azab, M. et al. Genetic variants in UNC93B1 predispose to childhood-onset systemic lupus erythematosus. Nat. Immunol. 25, 969\u2013980 (2024).","journal-title":"Nat. Immunol."},{"key":"1321_CR40","doi-asserted-by":"publisher","first-page":"1058","DOI":"10.1002\/art.42416","volume":"75","author":"C Xie","year":"2023","unstructured":"Xie, C. et al. De novo PACSIN1 gene variant found in childhood lupus and a role for PACSIN1\/TRAF4 complex in toll-like receptor 7 activation. Arthritis Rheumatol. 75, 1058\u20131071 (2023).","journal-title":"Arthritis Rheumatol."},{"key":"1321_CR41","doi-asserted-by":"publisher","first-page":"5981","DOI":"10.3390\/cimb45070378","volume":"45","author":"M Sestan","year":"2023","unstructured":"Sestan, M. et al. The role of genetic risk factors in pathogenesis of childhood-onset systemic lupus erythematosus. Curr. Issues Mol. Biol. 45, 5981\u20136002 (2023).","journal-title":"Curr. Issues Mol. Biol."},{"key":"1321_CR42","doi-asserted-by":"publisher","first-page":"1310","DOI":"10.1007\/s10875-022-01287-5","volume":"42","author":"M Tusseau","year":"2022","unstructured":"Tusseau, M. et al. DNASE1L3 deficiency, new phenotypes, and evidence for a transient type I IFN signaling. J. Clin. Immunol. 42, 1310\u20131320 (2022).","journal-title":"J. Clin. Immunol."},{"key":"1321_CR43","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.cell.2016.05.034","volume":"166","author":"V Sisirak","year":"2016","unstructured":"Sisirak, V. et al. Digestion of chromatin in apoptotic cell microparticles prevents autoimmunity. Cell 166, 88\u2013101 (2016).","journal-title":"Cell"},{"key":"1321_CR44","doi-asserted-by":"publisher","first-page":"1537","DOI":"10.1007\/s00467-017-3646-z","volume":"32","author":"C Picard","year":"2017","unstructured":"Picard, C. et al. Anti-C1q autoantibodies as markers of renal involvement in childhood-onset systemic lupus erythematosus. Pediatr. Nephrol. 32, 1537\u20131545 (2017).","journal-title":"Pediatr. Nephrol."},{"key":"1321_CR45","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20201138","volume":"218","author":"J Hartl","year":"2021","unstructured":"Hartl, J. et al. Autoantibody-mediated impairment of DNASE1L3 activity in sporadic systemic lupus erythematosus. J. Exp. Med. 218, e20201138 (2021).","journal-title":"J. Exp. Med."},{"key":"1321_CR46","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20232337","volume":"221","author":"M Jeanpierre","year":"2024","unstructured":"Jeanpierre, M. et al. Haploinsufficiency in PTPN2 leads to early-onset systemic autoimmunity from Evans syndrome to lupus. J. Exp. Med. 221, e20232337 (2024).","journal-title":"J. Exp. Med."},{"key":"1321_CR47","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-18925-4","volume":"11","author":"J Hadjadj","year":"2020","unstructured":"Hadjadj, J. et al. Early-onset autoimmunity associated with SOCS1 haploinsufficiency. Nat. Commun. 11, 5341 (2020).","journal-title":"Nat. Commun."},{"key":"1321_CR48","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1016\/j.gendis.2020.04.012","volume":"8","author":"Y Wang","year":"2021","unstructured":"Wang, Y. et al. Phenotypic characterization of patients with activated PI3K\u03b4 syndrome 1 presenting with features of systemic lupus erythematosus. Genes. Dis. 8, 907\u2013917 (2021).","journal-title":"Genes. Dis."},{"key":"1321_CR49","doi-asserted-by":"publisher","first-page":"101962","DOI":"10.1016\/j.berh.2024.101962","volume":"38","author":"J Thuner","year":"2024","unstructured":"Thuner, J., Cognard, J. & Belot, A. How to treat monogenic SLE? Best. Pract. Res. Clin. Rheumatol. 38, 101962 (2024).","journal-title":"Best. Pract. Res. Clin. Rheumatol."},{"key":"1321_CR50","doi-asserted-by":"publisher","first-page":"2161","DOI":"10.1002\/art.38008","volume":"65","author":"A Belot","year":"2013","unstructured":"Belot, A. et al. Protein kinase c\u03b4 deficiency causes Mendelian systemic lupus erythematosus with B cell-defective apoptosis and hyperproliferation. Arthritis Rheum. 65, 2161\u20132171 (2013).","journal-title":"Arthritis Rheum."},{"key":"1321_CR51","doi-asserted-by":"publisher","first-page":"671","DOI":"10.3899\/jrheum.220513","volume":"50","author":"MC Misztal","year":"2023","unstructured":"Misztal, M. C. et al. Genome-wide sequencing identified rare genetic variants for childhood-onset monogenic lupus. J. Rheumatol. 50, 671\u2013675 (2023).","journal-title":"J. Rheumatol."},{"key":"1321_CR52","doi-asserted-by":"publisher","DOI":"10.1136\/lupus-2024-001475","volume":"12","author":"L Lewandowski","year":"2025","unstructured":"Lewandowski, L. et al. Next generation sequencing analysis reveals complex genetic architecture of childhood-onset systemic lupus erythematosus. Lupus Sci. Med. 12, e001475 (2025).","journal-title":"Lupus Sci. Med."},{"key":"1321_CR53","doi-asserted-by":"publisher","DOI":"10.1002\/acr2.70003","volume":"7","author":"A Belot","year":"2025","unstructured":"Belot, A. et al. How (ultra-)rare gene variants improve our understanding of more common autoimmune and inflammatory diseases. ACR Open. Rheumatol. 7, e70003 (2025).","journal-title":"ACR Open. Rheumatol."},{"key":"1321_CR54","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1080\/15513815.2020.1764681","volume":"41","author":"M Keshavarz-Fathi","year":"2022","unstructured":"Keshavarz-Fathi, M. et al. DNA methylation of CD70 promoter in juvenile systemic lupus erythematosus. Fetal Pediatr. Pathol. 41, 58\u201367 (2022).","journal-title":"Fetal Pediatr. Pathol."},{"key":"1321_CR55","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1080\/15592294.2019.1585176","volume":"14","author":"KS Yeung","year":"2019","unstructured":"Yeung, K. S. et al. Cell lineage-specific genome-wide DNA methylation analysis of patients with paediatric-onset systemic lupus erythematosus. Epigenetics 14, 341\u2013351 (2019).","journal-title":"Epigenetics"},{"key":"1321_CR56","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1016\/j.aller.2020.03.014","volume":"48","author":"S Hanaei","year":"2020","unstructured":"Hanaei, S. et al. The status of FOXP3 gene methylation in pediatric systemic lupus erythematosus. Allergol. Immunopathol. 48, 332\u2013338 (2020).","journal-title":"Allergol. Immunopathol."},{"key":"1321_CR57","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1684\/ecn.2021.0469","volume":"32","author":"M Keshavarz-Fathi","year":"2021","unstructured":"Keshavarz-Fathi, M. et al. Aberrant DNA methylation of the promoters of JAK2 and SOCS3 in juvenile systemic lupus erythematosus. Eur. Cytokine Netw. 32, 48\u201354 (2021).","journal-title":"Eur. Cytokine Netw."},{"key":"1321_CR58","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1038\/s41390-024-03135-1","volume":"96","author":"J Wang","year":"2024","unstructured":"Wang, J. et al. DNA methylation of IFI44L as a potential blood biomarker for childhood-onset systemic lupus erythematosus. Pediatr. Res. 96, 494\u2013501 (2024).","journal-title":"Pediatr. Res."},{"key":"1321_CR59","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.adt5550","volume":"17","author":"R Narendra","year":"2025","unstructured":"Narendra, R. et al. Epigenetic attenuation of interferon signaling is associated with aging-related improvements in systemic lupus erythematosus. Sci. Transl. Med. 17, eadt5550 (2025).","journal-title":"Sci. Transl. Med."},{"key":"1321_CR60","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1136\/annrheumdis-2014-206334","volume":"75","author":"F Rees","year":"2016","unstructured":"Rees, F. et al. The incidence and prevalence of systemic lupus erythematosus in the UK, 1999-2012. Ann. Rheum. Dis. 75, 136\u2013141 (2016).","journal-title":"Ann. Rheum. Dis."},{"key":"1321_CR61","doi-asserted-by":"publisher","first-page":"2539","DOI":"10.3899\/jrheum.081141","volume":"36","author":"LT Hiraki","year":"2009","unstructured":"Hiraki, L. T. et al. Ethnic differences in pediatric systemic lupus erythematosus. J. Rheumatol. 36, 2539\u20132546 (2009).","journal-title":"J. Rheumatol."},{"key":"1321_CR62","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1177\/0961203320984251","volume":"30","author":"JS Massias","year":"2021","unstructured":"Massias, J. S. et al. Clinical and laboratory phenotypes in juvenile-onset systemic lupus erythematosus across ethnicities in the UK. Lupus 30, 597\u2013607 (2021).","journal-title":"Lupus"},{"key":"1321_CR63","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1002\/acr.21779","volume":"65","author":"DM Levy","year":"2013","unstructured":"Levy, D. M. et al. Influence of ethnicity on childhood-onset systemic lupus erythematosus: results from a multiethnic multicenter Canadian cohort. Arthritis Care Res. 65, 152\u2013160 (2013).","journal-title":"Arthritis Care Res."},{"key":"1321_CR64","doi-asserted-by":"publisher","first-page":"i15","DOI":"10.1093\/rheumatology\/keac695","volume":"62","author":"K Demkova","year":"2023","unstructured":"Demkova, K., Morris, D. L. & Vyse, T. J. Genetics of SLE: does this explain susceptibility and severity across racial groups? Rheumatology 62, i15\u2013i21 (2023).","journal-title":"Rheumatology"},{"key":"1321_CR65","doi-asserted-by":"publisher","DOI":"10.1136\/lupus-2023-001032","volume":"10","author":"L Arnaud","year":"2023","unstructured":"Arnaud, L. et al. Burden of systemic lupus erythematosus in clinical practice: baseline data from the SLE Prospective Observational Cohort Study (SPOCS) by interferon gene signature. Lupus Sci. Med. 10, e001032 (2023).","journal-title":"Lupus Sci. Med."},{"key":"1321_CR66","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2022.1112966","volume":"9","author":"GA Robinson","year":"2022","unstructured":"Robinson, G. A. et al. Editorial: sex bias in autoimmunity: from animal models to clinical research and applications. Front. Med. 9, 1112966 (2022).","journal-title":"Front. Med."},{"key":"1321_CR67","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2022.914016","volume":"9","author":"GA Robinson","year":"2022","unstructured":"Robinson, G. A. et al. Sex differences in lipid metabolism: implications for systemic lupus erythematosus and cardiovascular disease risk. Front. Med. 9, 914016 (2022).","journal-title":"Front. Med."},{"key":"1321_CR68","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2022.909789","volume":"9","author":"H Peckham","year":"2022","unstructured":"Peckham, H. et al. Gender-diverse inclusion in immunological research: benefits to science and health. Front. Med. 9, 909789 (2022).","journal-title":"Front. Med."},{"key":"1321_CR69","doi-asserted-by":"publisher","first-page":"e710","DOI":"10.1016\/S2665-9913(22)00198-9","volume":"4","author":"GA Robinson","year":"2022","unstructured":"Robinson, G. A. et al. Investigating sex differences in T regulatory cells from cisgender and transgender healthy individuals and patients with autoimmune inflammatory disease: a cross-sectional study. Lancet Rheumatol. 4, e710\u2013e724 (2022).","journal-title":"Lancet Rheumatol."},{"key":"1321_CR70","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20241253","volume":"222","author":"H Peckham","year":"2025","unstructured":"Peckham, H. et al. Estrogen influences class-switched memory B cell frequency only in humans with two X chromosomes. J. Exp. Med. 222, e20241253 (2025).","journal-title":"J. Exp. Med."},{"key":"1321_CR71","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.03167","volume":"9","author":"K Webb","year":"2018","unstructured":"Webb, K. et al. Sex and pubertal differences in the type 1 interferon pathway associate with both X chromosome number and serum sex hormone concentration. Front. Immunol. 9, 3167 (2018).","journal-title":"Front. Immunol."},{"key":"1321_CR72","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1038\/s41586-024-07789-z","volume":"633","author":"T Lakshmikanth","year":"2024","unstructured":"Lakshmikanth, T. et al. Immune system adaptation during gender-affirming testosterone treatment. Nature 633, 155\u2013164 (2024).","journal-title":"Nature"},{"key":"1321_CR73","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1177\/0961203312444771","volume":"21","author":"AI Renau","year":"2012","unstructured":"Renau, A. I. & Isenberg, D. A. Male versus female lupus: a comparison of ethnicity, clinical features, serology and outcome over a 30 year period. Lupus 21, 1041\u20131048 (2012).","journal-title":"Lupus"},{"key":"1321_CR74","doi-asserted-by":"publisher","DOI":"10.1186\/s13293-024-00650-y","volume":"15","author":"AA Vieira","year":"2024","unstructured":"Vieira, A. A. et al. Female-bias in systemic lupus erythematosus: how much is the X chromosome to blame? Biol. Sex. Differ. 15, 76 (2024).","journal-title":"Biol. Sex. Differ."},{"key":"1321_CR75","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1002\/JLB.6RI0319-094R","volume":"106","author":"CM Syrett","year":"2019","unstructured":"Syrett, C. M. & Anguera, M. C. When the balance is broken: X-linked gene dosage from two X chromosomes and female-biased autoimmunity. J. Leukoc. Biol. 106, 919\u2013932 (2019).","journal-title":"J. Leukoc. Biol."},{"key":"1321_CR76","doi-asserted-by":"publisher","first-page":"1290","DOI":"10.1002\/art.39560","volume":"68","author":"K Liu","year":"2016","unstructured":"Liu, K. et al. X chromosome dose and sex bias in autoimmune diseases: increased prevalence of 47,XXX in systemic lupus erythematosus and Sj\u00f6gren\u2019s syndrome. Arthritis Rheumatol. 68, 1290\u20131300 (2016).","journal-title":"Arthritis Rheumatol."},{"key":"1321_CR77","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.169344","volume":"8","author":"JD Crawford","year":"2023","unstructured":"Crawford, J. D. et al. The XIST lncRNA is a sex-specific reservoir of TLR7 ligands in SLE. JCI Insight 8, e169344 (2023).","journal-title":"JCI Insight"},{"key":"1321_CR78","doi-asserted-by":"publisher","first-page":"e485","DOI":"10.1016\/S2665-9913(20)30168-5","volume":"2","author":"GA Robinson","year":"2020","unstructured":"Robinson, G. A. et al. Disease-associated and patient-specific immune cell signatures in juvenile-onset systemic lupus erythematosus: patient stratification using a machine-learning approach. Lancet Rheumatol. 2, e485\u2013e496 (2020).","journal-title":"Lancet Rheumatol."},{"key":"1321_CR79","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1038\/s41590-020-0743-0","volume":"21","author":"D Nehar-Belaid","year":"2020","unstructured":"Nehar-Belaid, D. et al. Mapping systemic lupus erythematosus heterogeneity at the single-cell level. Nat. Immunol. 21, 1094\u20131106 (2020).","journal-title":"Nat. Immunol."},{"key":"1321_CR80","doi-asserted-by":"publisher","DOI":"10.1126\/science.abf1970","volume":"376","author":"RK Perez","year":"2022","unstructured":"Perez, R. K. et al. Single-cell RNA-seq reveals cell type-specific molecular and genetic associations to lupus. Science 376, eabf1970 (2022).","journal-title":"Science"},{"key":"1321_CR81","doi-asserted-by":"publisher","DOI":"10.1093\/cei\/uxae127","volume":"219","author":"A Radziszewska","year":"2025","unstructured":"Radziszewska, A. et al. Type I interferon and mitochondrial dysfunction are associated with dysregulated cytotoxic CD8+ T cell responses in juvenile systemic lupus erythematosus. Clin. Exp. Immunol. 219, uxae127 (2025).","journal-title":"Clin. Exp. Immunol."},{"key":"1321_CR82","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1208282","volume":"14","author":"RM Baxter","year":"2023","unstructured":"Baxter, R. M. et al. Expansion of extrafollicular B and T cell subsets in childhood-onset systemic lupus erythematosus. Front. Immunol. 14, 1208282 (2023).","journal-title":"Front. Immunol."},{"key":"1321_CR83","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.adl1666","volume":"16","author":"P Danaher","year":"2024","unstructured":"Danaher, P. et al. Childhood-onset lupus nephritis is characterized by complex interactions between kidney stroma and infiltrating immune cells. Sci. Transl. Med. 16, eadl1666 (2024).","journal-title":"Sci. Transl. Med."},{"key":"1321_CR84","doi-asserted-by":"publisher","first-page":"902","DOI":"10.1038\/s41590-019-0398-x","volume":"20","author":"A Arazi","year":"2019","unstructured":"Arazi, A. et al. The immune cell landscape in kidneys of patients with lupus nephritis. Nat. Immunol. 20, 902\u2013914 (2019).","journal-title":"Nat. Immunol."},{"key":"1321_CR85","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1016\/j.cell.2016.03.008","volume":"165","author":"R Banchereau","year":"2016","unstructured":"Banchereau, R. et al. Personalized immunomonitoring uncovers molecular networks that stratify lupus patients. Cell 165, 551\u2013565 (2016).","journal-title":"Cell"},{"key":"1321_CR86","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000032274","volume":"101","author":"J Ma","year":"2022","unstructured":"Ma, J. et al. Construction of molecular subgroups in childhood systemic lupus erythematosus using bioinformatics. Medicine 101, e32274 (2022).","journal-title":"Medicine"},{"key":"1321_CR87","doi-asserted-by":"publisher","DOI":"10.1136\/lupus-2022-000799","volume":"10","author":"MJ Wahadat","year":"2023","unstructured":"Wahadat, M. J. et al. Targeted multiomics in childhood-onset SLE reveal distinct biological phenotypes associated with disease activity: results from an explorative study. Lupus Sci. Med. 10, e000799 (2023).","journal-title":"Lupus Sci. Med."},{"key":"1321_CR88","first-page":"575","volume":"18","author":"A Psarras","year":"2022","unstructured":"Psarras, A., Wittmann, M. & Vital, E. M. Emerging concepts of type I interferons in SLE pathogenesis and therapy. Nat. Rev. Rheumatol. 18, 575\u2013590 (2022).","journal-title":"Nat. Rev. Rheumatol."},{"key":"1321_CR89","doi-asserted-by":"publisher","first-page":"3938","DOI":"10.1093\/rheumatology\/keae643","volume":"64","author":"V Natoli","year":"2025","unstructured":"Natoli, V. et al. Elevated serum interferon-\u03b12 associates with activity and flare risk in Juvenile-onset systemic lupus erythematosus. Rheumatology 64, 3938\u20133946 (2025).","journal-title":"Rheumatology"},{"key":"1321_CR90","doi-asserted-by":"publisher","first-page":"2872","DOI":"10.1093\/rheumatology\/keac698","volume":"62","author":"MJ Wahadat","year":"2023","unstructured":"Wahadat, M. J. et al. Serum IFN\u03b12 levels are associated with disease activity and outperform IFN-I gene signature in a longitudinal childhood-onset SLE cohort. Rheumatology 62, 2872\u20132879 (2023).","journal-title":"Rheumatology"},{"key":"1321_CR91","doi-asserted-by":"publisher","first-page":"4344","DOI":"10.1093\/rheumatology\/keac083","volume":"61","author":"MJ Wahadat","year":"2022","unstructured":"Wahadat, M. J. et al. Gene signature fingerprints stratify SLE patients in groups with similar biological disease profiles: a multicentre longitudinal study. Rheumatology 61, 4344\u20134354 (2022).","journal-title":"Rheumatology"},{"key":"1321_CR92","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacig.2025.100450","volume":"4","author":"A Nombel","year":"2025","unstructured":"Nombel, A. et al. Profiling type I and II interferon responses reveals distinct subgroups of pediatric patients with autoinflammatory disorders. J. Allergy Clin. Immunol. Glob. 4, 100450 (2025).","journal-title":"J. Allergy Clin. Immunol. Glob."},{"key":"1321_CR93","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrm.2022.100894","volume":"4","author":"HF Bradford","year":"2023","unstructured":"Bradford, H. F. et al. Inactive disease in patients with lupus is linked to autoantibodies to type I interferons that normalize blood IFN\u03b1 and B cell subsets. Cell Rep. Med. 4, 100894 (2023).","journal-title":"Cell Rep. Med."},{"key":"1321_CR94","doi-asserted-by":"publisher","first-page":"5096","DOI":"10.1093\/rheumatology\/keaf275","volume":"64","author":"MB Mac\u00eado","year":"2025","unstructured":"Mac\u00eado, M. B. et al. Anti-mitochondrial antibodies as markers of disease activity in childhood-onset systemic lupus erythematosus: a longitudinal cohort study. Rheumatology 64, 5096\u20135100 (2025).","journal-title":"Rheumatology"},{"key":"1321_CR95","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1084\/jem.20151876","volume":"213","author":"S Caielli","year":"2016","unstructured":"Caielli, S. et al. Oxidized mitochondrial nucleoids released by neutrophils drive type I interferon production in human lupus. J. Exp. Med. 213, 697\u2013713 (2016).","journal-title":"J. Exp. Med."},{"key":"1321_CR96","doi-asserted-by":"publisher","first-page":"1733","DOI":"10.1007\/s10067-023-06645-1","volume":"42","author":"C Ciurtin","year":"2023","unstructured":"Ciurtin, C. Potential relevance of type I interferon-related biomarkers for the management of polygenic autoimmune rheumatic diseases with childhood onset. Clin. Rheumatol. 42, 1733\u20131736 (2023).","journal-title":"Clin. Rheumatol."},{"key":"1321_CR97","doi-asserted-by":"publisher","first-page":"1377","DOI":"10.1007\/s00467-020-04686-1","volume":"36","author":"L Oni","year":"2021","unstructured":"Oni, L. et al. Kidney outcomes for children with lupus nephritis. Pediatr. Nephrol. 36, 1377\u20131385 (2021).","journal-title":"Pediatr. Nephrol."},{"key":"1321_CR98","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22147619","volume":"22","author":"J Greenan-Barrett","year":"2021","unstructured":"Greenan-Barrett, J. et al. Biomarkers associated with organ-specific involvement in juvenile systemic lupus erythematosus. Int. J. Mol. Sci. 22, 7619 (2021).","journal-title":"Int. J. Mol. Sci."},{"key":"1321_CR99","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.885307","volume":"13","author":"SA Soliman","year":"2022","unstructured":"Soliman, S. A. et al. Urine ALCAM, PF4 and VCAM-1 surpass conventional metrics in identifying nephritis disease activity in childhood-onset systemic lupus erythematosus. Front. Immunol. 13, 885307 (2022).","journal-title":"Front. Immunol."},{"key":"1321_CR100","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2023.103165","volume":"143","author":"Y Li","year":"2024","unstructured":"Li, Y. et al. Proximity extension assay proteomics and renal single cell transcriptomics uncover novel urinary biomarkers for active lupus nephritis. J. Autoimmun. 143, 103165 (2024).","journal-title":"J. Autoimmun."},{"key":"1321_CR101","doi-asserted-by":"publisher","first-page":"e258","DOI":"10.1016\/S2665-9913(24)00085-7","volume":"6","author":"C Ciurtin","year":"2024","unstructured":"Ciurtin, C. et al. Cardiovascular risk in young people with childhood onset systemic lupus erythematosus. Lancet Rheumatol. 6, e258\u2013e263 (2024).","journal-title":"Lancet Rheumatol."},{"key":"1321_CR102","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1007\/s10067-022-06093-3","volume":"41","author":"C Ciurtin","year":"2022","unstructured":"Ciurtin, C. et al. Comorbidity in young patients with juvenile systemic lupus erythematosus: how can we improve management? Clin. Rheumatol. 41, 961\u2013964 (2022).","journal-title":"Clin. Rheumatol."},{"key":"1321_CR103","doi-asserted-by":"publisher","DOI":"10.3390\/metabo12010003","volume":"12","author":"GA Robinson","year":"2022","unstructured":"Robinson, G. A. et al. Metabolomics defines complex patterns of dyslipidaemia in juvenile-SLE patients associated with inflammation and potential cardiovascular disease risk. Metabolites 12, 3 (2022).","journal-title":"Metabolites"},{"key":"1321_CR104","doi-asserted-by":"publisher","first-page":"2741","DOI":"10.1093\/rheumatology\/kead646","volume":"63","author":"EC Jury","year":"2023","unstructured":"Jury, E. C. et al. Systemic lupus erythematosus patients have unique changes in serum metabolic profiles across age associated with cardiometabolic risk. Rheumatology 63, 2741\u20132753 (2023).","journal-title":"Rheumatology"},{"key":"1321_CR105","doi-asserted-by":"publisher","DOI":"10.1172\/JCI148552","volume":"132","author":"G Robinson","year":"2022","unstructured":"Robinson, G. et al. Lipid metabolism in autoimmune rheumatic disease: implications for modern and conventional therapies. J. Clin. Invest. 132, e148552 (2022).","journal-title":"J. Clin. Invest."},{"key":"1321_CR106","doi-asserted-by":"publisher","first-page":"1496","DOI":"10.1002\/art.24469","volume":"60","author":"LE Schanberg","year":"2009","unstructured":"Schanberg, L. E. et al. Premature atherosclerosis in pediatric systemic lupus erythematosus: risk factors for increased carotid intima-media thickness in the atherosclerosis prevention in pediatric lupus erythematosus cohort. Arthritis Rheum. 60, 1496\u20131507 (2009).","journal-title":"Arthritis Rheum."},{"key":"1321_CR107","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1136\/ard.2010.136762","volume":"70","author":"MA Petri","year":"2011","unstructured":"Petri, M. A. et al. Lupus Atherosclerosis Prevention Study (LAPS). Ann. Rheum. Dis. 70, 760\u2013765 (2011).","journal-title":"Ann. Rheum. Dis."},{"key":"1321_CR108","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1002\/art.42722","volume":"76","author":"J Peng","year":"2024","unstructured":"Peng, J. et al. Atherosclerosis progression in the APPLE trial can be predicted in young people with juvenile-onset systemic lupus erythematosus using a novel lipid metabolomic signature. Arthritis Rheumatol. 76, 455\u2013468 (2024).","journal-title":"Arthritis Rheumatol."},{"key":"1321_CR109","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2021.103243","volume":"65","author":"GA Robinson","year":"2021","unstructured":"Robinson, G. A. et al. Increased apolipoprotein-B:A1 ratio predicts cardiometabolic risk in patients with juvenile onset SLE. EBioMedicine 65, 103243 (2021).","journal-title":"EBioMedicine"},{"key":"1321_CR110","doi-asserted-by":"publisher","DOI":"10.1136\/lupus-2024-001194","volume":"11","author":"C Ciurtin","year":"2024","unstructured":"Ciurtin, C. et al. Investigation of the performance of validated cardiovascular risk scores in a global (UK\/US) cohort of young people with childhood-onset systemic lupus erythematosus. Lupus Sci. Med. 11, e001194 (2024).","journal-title":"Lupus Sci. Med."},{"key":"1321_CR111","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.124.036507","volume":"14","author":"L Woodridge","year":"2025","unstructured":"Woodridge, L. et al. Subclinical atherosclerosis risk can be predicted in female patients with systemic lupus erythematosus using metabolomic signatures: an observational study. J. Am. Heart Assoc. 14, e036507 (2025).","journal-title":"J. Am. Heart Assoc."},{"key":"1321_CR112","doi-asserted-by":"publisher","first-page":"545","DOI":"10.2217\/bmm.15.26","volume":"9","author":"TB Rubinstein","year":"2015","unstructured":"Rubinstein, T. B., Putterman, C. & Goilav, B. Biomarkers for CNS involvement in pediatric lupus. Biomark. Med. 9, 545\u2013558 (2015).","journal-title":"Biomark. Med."},{"key":"1321_CR113","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1002\/art.42736","volume":"76","author":"H van der Heijden","year":"2024","unstructured":"van der Heijden, H. et al. Implications of inflammatory processes on a developing central nervous system in childhood-onset systemic lupus erythematosus. Arthritis Rheumatol. 76, 332\u2013344 (2024).","journal-title":"Arthritis Rheumatol."},{"key":"1321_CR114","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1177\/0961203319855125","volume":"28","author":"E Moraitis","year":"2019","unstructured":"Moraitis, E. et al. Aquaporin-4 IgG antibody-related disorders in patients with juvenile systemic lupus erythematosus. Lupus 28, 1243\u20131249 (2019).","journal-title":"Lupus"},{"key":"1321_CR115","doi-asserted-by":"publisher","DOI":"10.1136\/lupus-2014-000038","volume":"1","author":"HI Brunner","year":"2014","unstructured":"Brunner, H. I. et al. Blood-based candidate biomarkers of the presence of neuropsychiatric systemic lupus erythematosus in children. Lupus Sci. Med. 1, e000038 (2014).","journal-title":"Lupus Sci. Med."},{"key":"1321_CR116","doi-asserted-by":"publisher","first-page":"1116","DOI":"10.1177\/09612033241272961","volume":"33","author":"R Kammeyer","year":"2024","unstructured":"Kammeyer, R. et al. Blood-based biomarkers of neuronal and glial injury in active major neuropsychiatric systemic lupus erythematosus. Lupus 33, 1116\u20131129 (2024).","journal-title":"Lupus"},{"key":"1321_CR117","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.ncl.2009.09.004","volume":"28","author":"E Muscal","year":"2010","unstructured":"Muscal, E. & Brey, R. L. Neurologic manifestations of systemic lupus erythematosus in children and adults. Neurol. Clin. 28, 61\u201373 (2010).","journal-title":"Neurol. Clin."},{"key":"1321_CR118","doi-asserted-by":"publisher","DOI":"10.1136\/lupus-2024-001214","volume":"11","author":"D Vald\u00e9s Cabrera","year":"2024","unstructured":"Vald\u00e9s Cabrera, D. et al. Effects of systemic lupus erythematosus on the brain: a systematic review of structural MRI findings and their relationships with cognitive dysfunction. Lupus Sci. Med. 11, e001214 (2024).","journal-title":"Lupus Sci. Med."},{"key":"1321_CR119","doi-asserted-by":"publisher","first-page":"1529","DOI":"10.1093\/rheumatology\/keab530","volume":"61","author":"RB Frittoli","year":"2022","unstructured":"Frittoli, R. B. et al. Axonal dysfunction is associated with interferon-\u03b3 levels in childhood-onset systemic lupus erythematosus: a multivoxel magnetic resonance spectroscopy study. Rheumatology 61, 1529\u20131537 (2022).","journal-title":"Rheumatology"},{"key":"1321_CR120","doi-asserted-by":"publisher","DOI":"10.1186\/ar4197","volume":"15","author":"MW DiFrancesco","year":"2013","unstructured":"DiFrancesco, M. W. et al. Functional neuronal network activity differs with cognitive dysfunction in childhood-onset systemic lupus erythematosus. Arthritis Res. Ther. 15, R40 (2013).","journal-title":"Arthritis Res. Ther."},{"key":"1321_CR121","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1002\/acr.22571","volume":"67","author":"P Vega-Fernandez","year":"2015","unstructured":"Vega-Fernandez, P. et al. Cognitive performance scores for the pediatric automated neuropsychological assessment metrics in childhood-onset systemic lupus erythematosus. Arthritis Care Res. 67, 1119\u20131127 (2015).","journal-title":"Arthritis Care Res."},{"key":"1321_CR122","doi-asserted-by":"publisher","DOI":"10.1016\/j.berh.2023.101865","volume":"37","author":"A Askanase","year":"2023","unstructured":"Askanase, A. et al. New and future therapies: changes in the therapeutic armamentarium for SLE. Best Pract. Res. Clin. Rheumatol. 37, 101865 (2023).","journal-title":"Best Pract. Res. Clin. Rheumatol."},{"key":"1321_CR123","doi-asserted-by":"publisher","first-page":"i1","DOI":"10.1093\/rheumatology\/kead058","volume":"62","author":"IN Bruce","year":"2023","unstructured":"Bruce, I. N. Health inequalities and systemic lupus erythematosus: a global challenge. Rheumatology 62, i1\u2013i3 (2023).","journal-title":"Rheumatology"},{"key":"1321_CR124","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1177\/0961203317741565","volume":"27","author":"Z Ekinci","year":"2018","unstructured":"Ekinci, Z. & Ozturk, K. Systemic lupus erythematosus with C1q deficiency: treatment with fresh frozen plasma. Lupus 27, 134\u2013138 (2018).","journal-title":"Lupus"},{"key":"1321_CR125","doi-asserted-by":"publisher","first-page":"184","DOI":"10.5152\/eurjrheum.2020.20087","volume":"7","author":"L Akbar","year":"2020","unstructured":"Akbar, L., Alsagheir, R. & Al-Mayouf, S. M. Efficacy of a sequential treatment by belimumab in monogenic systemic lupus erythematosus. Eur. J. Rheumatol. 7, 184\u2013189 (2020).","journal-title":"Eur. J. Rheumatol."},{"key":"1321_CR126","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1007\/s12185-020-03004-7","volume":"113","author":"R Matsumura","year":"2021","unstructured":"Matsumura, R. et al. Bone marrow transplantation from a human leukocyte antigen-mismatched unrelated donor in a case with C1q deficiency associated with refractory systemic lupus erythematosus. Int. J. Hematol. 113, 302\u2013307 (2021).","journal-title":"Int. J. Hematol."},{"key":"1321_CR127","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20230263","volume":"220","author":"JS Tilstra","year":"2023","unstructured":"Tilstra, J. S. et al. B cell-intrinsic Myd88 regulates disease progression in murine lupus. J. Exp. Med. 220, e20230263 (2023).","journal-title":"J. Exp. Med."},{"key":"1321_CR128","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1002\/eji.202149361","volume":"52","author":"C Cenac","year":"2022","unstructured":"Cenac, C., Ducatez, M. F. & Guery, J. C. Hydroxychloroquine inhibits proteolytic processing of endogenous TLR7 protein in human primary plasmacytoid dendritic cells. Eur. J. Immunol. 52, 54\u201361 (2022).","journal-title":"Eur. J. Immunol."},{"key":"1321_CR129","doi-asserted-by":"publisher","DOI":"10.1016\/j.clim.2023.109593","volume":"250","author":"A Doroudchi","year":"2023","unstructured":"Doroudchi, A. & Butte, M. First reported use of anifrolumab to treat a monogenic interferonopathy (DNASE2 loss of function). Clin. Immunol. 250, 109593 (2023).","journal-title":"Clin. Immunol."},{"key":"1321_CR130","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbspin.2023.105523","volume":"90","author":"R Felten","year":"2023","unstructured":"Felten, R., Scherlinger, M., Mertz, P., Chasset, F. & Arnaud, L.\u00a0New biologics and targeted therapies in systemic lupus: from new molecular targets to new indications. A systematic review. Jt Bone Spine 90, 105523 (2023).","journal-title":"A systematic review. Jt Bone Spine"},{"key":"1321_CR131","doi-asserted-by":"publisher","DOI":"10.1186\/s12969-023-00916-6","volume":"21","author":"J Wu","year":"2023","unstructured":"Wu, J. et al. Case report: JAK1\/2 inhibition with baricitinib in the treatment of STING-associated vasculopathy with onset in infancy. Pediatr. Rheumatol. Online J. 21, 131 (2023).","journal-title":"Pediatr. Rheumatol. Online J."},{"key":"1321_CR132","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1038\/s41577-021-00524-z","volume":"21","author":"A Decout","year":"2021","unstructured":"Decout, A. et al. The cGAS\u2013STING pathway as a therapeutic target in inflammatory diseases. Nat. Rev. Immunol. 21, 548\u2013569 (2021).","journal-title":"Nat. Rev. Immunol."},{"key":"1321_CR133","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1007\/s00011-021-01479-6","volume":"70","author":"G Su","year":"2021","unstructured":"Su, G. et al. Analysis of five cases of monogenic lupus related to primary immunodeficiency diseases. Inflamm. Res. 70, 1211\u20131216 (2021).","journal-title":"Inflamm. Res."},{"key":"1321_CR134","doi-asserted-by":"publisher","DOI":"10.1186\/s12969-018-0278-1","volume":"16","author":"L Lei","year":"2018","unstructured":"Lei, L. et al. Successful use of ofatumumab in two cases of early-onset juvenile SLE with thrombocytopenia caused by a mutation in protein kinase C \u03b4. Pediatr. Rheumatol. Online J. 16, 61 (2018).","journal-title":"Pediatr. Rheumatol. Online J."},{"key":"1321_CR135","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.4049\/jimmunol.2200818","volume":"210","author":"M Moreews","year":"2023","unstructured":"Moreews, M. et al. mTOR activation underlies enhanced B cell proliferation and autoimmunity in PrkcdG510S\/G510S mice. J. Immunol. 210, 1209\u20131221 (2023).","journal-title":"J. Immunol."},{"key":"1321_CR136","doi-asserted-by":"publisher","first-page":"1282","DOI":"10.1016\/j.jid.2023.12.007","volume":"144","author":"I Elhani","year":"2024","unstructured":"Elhani, I. et al. A20 haploinsufficiency: a systematic review of 177 cases. J. Investig. Dermatol. 144, 1282\u20131294.e8 (2024).","journal-title":"J. Investig. Dermatol."},{"key":"1321_CR137","doi-asserted-by":"publisher","DOI":"10.3389\/fped.2022.990008","volume":"10","author":"J Liu","year":"2023","unstructured":"Liu, J. et al. Haploinsufficiency of A20 in a Chinese child caused by loss-of-function mutations in TNFAIP3: a case report and review of the literature. Front. Pediatrics 10, 990008 (2023).","journal-title":"Front. Pediatrics"},{"key":"1321_CR138","doi-asserted-by":"publisher","first-page":"1340","DOI":"10.1136\/annrheumdis-2020-217101","volume":"79","author":"HI Brunner","year":"2020","unstructured":"Brunner, H. I. et al. Safety and efficacy of intravenous belimumab in children with systemic lupus erythematosus: results from a randomised, placebo-controlled trial. Ann. Rheum. Dis. 79, 1340\u20131348 (2020).","journal-title":"Ann. Rheum. Dis."},{"key":"1321_CR139","doi-asserted-by":"publisher","DOI":"10.1093\/rap\/rkad093","volume":"7","author":"MY Md Yusof","year":"2023","unstructured":"Md Yusof, M. Y. et al. Management and treatment of children, young people and adults with systemic lupus erythematosus: British Society for Rheumatology guideline scope. Rheumatol. Adv. Pract. 7, rkad093 (2023).","journal-title":"Rheumatol. Adv. Pract."},{"key":"1321_CR140","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1002\/art.43212","volume":"77","author":"LR Sammaritano","year":"2025","unstructured":"Sammaritano, L. R. et al. 2024 American College of Rheumatology (ACR) guideline for the screening, treatment, and management of lupus nephritis. Arthritis Rheumatol. 77, 1115\u20131135 (2025).","journal-title":"Arthritis Rheumatol."},{"key":"1321_CR141","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1136\/ard-2023-224762","volume":"83","author":"A Fanouriakis","year":"2024","unstructured":"Fanouriakis, A. et al. EULAR recommendations for the management of systemic lupus erythematosus: 2023 update. Ann. Rheum. Dis. 83, 15\u201329 (2024).","journal-title":"Ann. Rheum. Dis."},{"key":"1321_CR142","doi-asserted-by":"publisher","DOI":"10.1136\/lupus-2023-000987","volume":"11","author":"TW Lin","year":"2024","unstructured":"Lin, T. W. et al. Rituximab as an effective add-on maintenance therapy for disease activities in childhood-onset systemic lupus erythematosus. Lupus Sci. Med. 11, e000987 (2024).","journal-title":"Lupus Sci. Med."},{"key":"1321_CR143","doi-asserted-by":"publisher","first-page":"4921","DOI":"10.1093\/rheumatology\/keaf231","volume":"64","author":"J Cognard","year":"2025","unstructured":"Cognard, J. et al. Indications, efficacy, safety of rituximab in childhood-onset systemic lupus erythematosus: a retrospective study of the JIR cohort. Rheumatology 64, 4921\u20134929 (2025).","journal-title":"Rheumatology"},{"key":"1321_CR144","doi-asserted-by":"publisher","first-page":"541","DOI":"10.3899\/jrheum.140863","volume":"42","author":"A Tambralli","year":"2015","unstructured":"Tambralli, A. et al. Safety and efficacy of rituximab in childhood-onset systemic lupus erythematosus and other rheumatic diseases. J. Rheumatol. 42, 541\u2013546 (2015).","journal-title":"J. Rheumatol."},{"key":"1321_CR145","doi-asserted-by":"publisher","first-page":"3987","DOI":"10.1007\/s00431-024-05662-9","volume":"183","author":"H Li","year":"2024","unstructured":"Li, H. et al. Efficacy and safety of belimumab combined with the standard regimen in treating children with lupus nephritis. Eur. J. Pediatr. 183, 3987\u20133995 (2024).","journal-title":"Eur. J. Pediatr."},{"key":"1321_CR146","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1177\/0961203320981137","volume":"30","author":"OK Cinar","year":"2021","unstructured":"Cinar, O. K. et al. Ofatumumab use in juvenile systemic lupus erythematosus: a single centre experience. Lupus 30, 527\u2013530 (2021).","journal-title":"Lupus"},{"key":"1321_CR147","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1111\/nep.14406","volume":"29","author":"H Tanaka","year":"2024","unstructured":"Tanaka, H., Aizawa, T. & Endo, M. Long-term outcome of tacrolimus-based immunosuppressive treatment for patients with paediatric-onset lupus nephritis. Nephrology 29, 901\u2013908 (2024).","journal-title":"Nephrology"},{"key":"1321_CR148","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1038\/s41584-023-00948-y","volume":"19","author":"S Fasano","year":"2023","unstructured":"Fasano, S. et al. Precision medicine in systemic lupus erythematosus. Nat. Rev. Rheumatol. 19, 331\u2013342 (2023).","journal-title":"Nat. Rev. Rheumatol."},{"key":"1321_CR149","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2024.103692","volume":"24","author":"X He","year":"2025","unstructured":"He, X. et al. Treatment of two pediatric patients with refractory systemic lupus erythematosus using CD19-targeted CAR T-cells. Autoimmun. Rev. 24, 103692 (2025).","journal-title":"Autoimmun. Rev."},{"key":"1321_CR150","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1038\/s41584-025-01272-3","volume":"21","author":"H Wobma","year":"2025","unstructured":"Wobma, H. et al. CAR T cell therapy for children with rheumatic disease: the time is now. Nat. Rev. Rheumatol. 21, 494\u2013506 (2025).","journal-title":"Nat. Rev. Rheumatol."},{"key":"1321_CR151","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1002\/art.41930","volume":"74","author":"NE Chalhoub","year":"2022","unstructured":"Chalhoub, N. E. et al. International consensus for the dosing of corticosteroids in childhood-onset systemic lupus erythematosus with proliferative lupus nephritis. Arthritis Rheumatol. 74, 263\u2013273 (2022).","journal-title":"Arthritis Rheumatol."},{"key":"1321_CR152","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1136\/ard-2022-223328","volume":"82","author":"EMD Smith","year":"2023","unstructured":"Smith, E. M. D. et al. Towards development of treat to target (T2T) in childhood-onset systemic lupus erythematosus: PReS-endorsed overarching principles and points-to-consider from an international task force. Ann. Rheum. Dis. 82, 788\u2013798 (2023).","journal-title":"Ann. Rheum. Dis."},{"key":"1321_CR153","doi-asserted-by":"publisher","first-page":"1615","DOI":"10.1136\/annrheumdis-2015-207726","volume":"75","author":"K Franklyn","year":"2016","unstructured":"Franklyn, K. et al. Definition and initial validation of a Lupus Low Disease Activity State (LLDAS). Ann. Rheum. Dis. 75, 1615\u20131621 (2016).","journal-title":"Ann. Rheum. Dis."},{"key":"1321_CR154","doi-asserted-by":"publisher","DOI":"10.1016\/j.clim.2023.109296","volume":"250","author":"EMD Smith","year":"2023","unstructured":"Smith, E. M. D. et al. PReS-endorsed international childhood lupus T2T task force definition of childhood lupus low disease activity state (cLLDAS). Clin. Immunol. 250, 109296 (2023).","journal-title":"Clin. Immunol."},{"key":"1321_CR155","doi-asserted-by":"publisher","DOI":"10.1136\/lupus-2021-000538","volume":"8","author":"RF van Vollenhoven","year":"2021","unstructured":"van Vollenhoven, R. F. et al. 2021 DORIS definition of remission in SLE: final recommendations from an international task force. Lupus Sci. Med. 8, e000538 (2021).","journal-title":"Lupus Sci. Med."},{"key":"1321_CR156","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1002\/acr.25443","volume":"77","author":"WD Soulsby","year":"2025","unstructured":"Soulsby, W. D. et al. Racial disparities and achievement of the low lupus disease activity state: a CARRA registry study. Arthritis Care Res. 77, 38\u201349 (2025).","journal-title":"Arthritis Care Res."},{"key":"1321_CR157","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1136\/ard-2024-226528","volume":"84","author":"RE Sadun","year":"2025","unstructured":"Sadun, R. E. et al. Development of CARRA\/PReS-endorsed consensus core and expanded datasets in childhood-onset systemic lupus erythematosus for international registry-based research. Ann. Rheum. Dis. 84, 158\u2013168 (2025).","journal-title":"Ann. Rheum. Dis."},{"key":"1321_CR158","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2022.904435","volume":"9","author":"C Ciurtin","year":"2025","unstructured":"Ciurtin, C., Pineda-Torra, I., Jury, E. C. & Robinson, G. A. CD8+ T-cells in juvenile-onset SLE: from pathogenesis to comorbidities. Front. Med. 9, 904435 (2025).","journal-title":"Front. Med."}],"container-title":["Nature Reviews Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41584-025-01321-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41584-025-01321-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41584-025-01321-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,22]],"date-time":"2025-12-22T01:01:46Z","timestamp":1766365306000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41584-025-01321-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,19]]},"references-count":158,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["1321"],"URL":"https:\/\/doi.org\/10.1038\/s41584-025-01321-x","relation":{},"ISSN":["1759-4790","1759-4804"],"issn-type":[{"value":"1759-4790","type":"print"},{"value":"1759-4804","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,19]]},"assertion":[{"value":"17 October 2025","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 November 2025","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}